New blood test could spare kidney patients painful biopsies

NCT ID NCT07006831

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study collects blood samples from 400 kidney transplant patients who need a biopsy. Researchers will use the samples to develop a non-invasive test that measures donor DNA in the blood to check the health of the transplanted kidney. The goal is to replace invasive biopsies with a simple blood draw.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Brigham & Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Piedmont Healthcare

    RECRUITING

    Atlanta, Georgia, 30309, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Scripps Health

    RECRUITING

    San Diego, California, 92037, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of California San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Maryland Baltimore

    RECRUITING

    Baltimore, Maryland, 21201, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Utah

    RECRUITING

    Salt Lake City, Utah, 84132, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test to check if a kidney transplant is healthy, reducing the need for invasive biopsies.

What could go wrong

This is an early-stage sample collection study, not a treatment trial. The test may not prove accurate or may not be developed further.

Conditions

The condition(s) this trial relates to.

impaired renal function disease kidney disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.